Enhanced antitumor activity of epirubicin combined with cerulenin in osteosarcoma

Liu,Z. L.; Wang,G.; Shu,Y.; Zou,P. A.; Zhou,Y.; Yin,Q. S.

doi:10.3892/mmr.2011.661

Enhanced antitumor activity of epirubicin combined with cerulenin in osteosarcoma

Authors:
- Z. L. Liu
- G. Wang
- Y. Shu
- P. A. Zou
- Y. Zhou
- Q. S. Yin
View Affiliations

Affiliations: Graduate School of Southern Medical University, Guangzhou, Guangdong, P.R. China, Department of Orthopedics, Third Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, P.R. China, Department of Orthopedics, First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, P.R. China, Guangzhou General Hospital of Guangzhou Military Region, Guangzhou, Guangdong, P.R. China
Published online on: November 2, 2011 https://doi.org/10.3892/mmr.2011.661
Pages: 326-330

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Osteosarcoma (OS) is the most common primary malignant neoplasm in children and adolescents. Epirubicin is one of the chemotherapeutic agents currently used for the treatment of OS; however, the efficacy of chemotherapy is hampered by the acquired drug resistance of OS. Cerulenin, an inhibitor of fatty acid synthase, has been defined as a candidate tumor suppressor. In this study, we explored the combined effect of cerulenin plus the chemotherapy drug, epirubicin, on human OS U2-OS cells in vitro and in vivo. We demonstrated that cerulenin plus epirubicin induced synergistic growth inhibition and enhanced apoptosis in U2-OS cells. We also demonstrated that cerulenin plus epirubicin synergistically suppressed tumor growth in subcutaneously xenografted U2-OS cells in athymic nude mice. Our results indicate that cerulenin enhances the anti-OS effects of epirubicin in vivo and in vitro.